Specialized in liquid pharmaceuticals: Blow-Fill-Seal (BFS) technology and Nasal Spray.

Read More


Your partner in bringing medical innovation to the market.

Read More

About Curida

Highly skilled Development and Manufacturing Organization with ambitions.

Read More

Contact Curida

Pharmaceutical Development or Manufacturing needs?

Contact Us

Operational Excellence in Pharmaceuticals since 1974

Curida is a Contract Development and Manufacturing Organization (CDMO) within the Pharmaceutical industry, based in Norway.

Curida has core competency in state-of-the-art manufacturing of Liquid Pharmaceuticals based on sterile unit-dose Blow-Fill-Seal (BFS) technology and Nasal Spray. The development expertise covers the full service for the development of nasal drug products, and experience on operational excellence is spanning more than 40 years. Curida has produced BFS products since 1989 and offers over three decades of know-how in this technology. Customers range from small start-ups and early stage Biotech companies to Big Pharma.

Curida is a part of an exciting and growing life science sector in Norway, and our vision is to be the National Centre for Industrialization of Medical Innovation. Curida is an active partner and member of Oslo Cancer Cluster.

Latest News

Curida presented at the NHO’s Annual Conference 2019, ‘We and the world’.

Published: 18 Jan 2019

The EEA and the fight against trade barriers and protectionism were the important topics of the NHO Annual Conference on January 9, 2019. As a small country in a challenging and unpredictable world, Norway is totally dependent on trade with […]

Read More

Curida attracts new investors

Published: 24 Sep 2018

The Norwegian pharmaceutical manufacturer Curida has attracted yet another strong private investor. Stokke Industri AS joins the Curida team along with Canica, Klaveness Marine and Investinor. Curida has now raised more than 100 million NOK from external investors. – The […]

Read More